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Background: Lower body mass index (BMI) is associated with worse pulmonary function
in cystic fibrosis (CF). Hypothesis: lean body mass (LBM) is more strongly associated with
pulmonary function than BMI is.
Methods:Anthropometrics, body composition by dual x-ray absorptiometry, and pulmonary
function were determined in pancreatic insufficient CF (PI-CF) youth. Sex and age-adjusted
Z -scores (BMI-Z, LBMI-Z, FMI-Z ) were generated for CF and controls. (1) Associations of
BMI-Z with LBMI-Z and FMI-Z and (2) age-adjusted associations of BMI-Z, LBMI-Z, and
FMI-Z with FEV1%-predicted were tested.
Results:Two hundred eight PI-CF subjects had lower BMI-Z, LBMI-Z, and FMI-Z compared
to 390 controls. BMI-Z was associated with lower LBMI-Z (p<0.0001) in PI-CF. In females,
LBMI-Z and BMI-Z were positively associated with FEV1%-predicted; this relationship did
not persist for FMI-Z after adjustment for LBMI-Z. In males, only LBMI-Z and BMI-Z were
associated with FEV1%-predicted.
Conclusion: In PI-CF youth, deficits in LBM were apparent. At lower BMI percentiles, BMI
may not accurately depict LBM in PI-CF. In under-nourished PI-CF youth, this preservation
of FM in preference to LBM is relevant since LBMI-Z, but not FMI-Z, is positively associ-
ated with FEV1%-predicted. Lean body mass index is more strongly associated with lung
function compared to BMI, especially in the under-nourished child and adolescent with
PI-CF.
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INTRODUCTION
Stature, weight, and body mass index (BMI) are typically used to
assess nutritional status in cystic fibrosis (CF) since these measures
are obtained in clinical practice and reference data are available.
Moreover, since poor nutritional status is associated with worse
pulmonary function in CF (1–3), the CF foundation (CFF) clini-
cal care guidelines set a goal to maintain BMI above 50th percentile
in children and above 22 or 23 in adults with CF in order to support
optimal pulmonary function (4).
The association of higher BMI with better pulmonary func-
tion in CF is hypothesized to reflect the impact of lean body
mass (LBM) upon respiratory muscle strength and physical well-
being (5, 6). However, in the general population, BMI is used
to indicate body fatness. Studies directly measuring body com-
position in CF are limited (5, 7, 8). Their results are difficult
to generalize in children and adolescents with CF due to inclu-
sion of adults, differing body composition methodologies, small
sample sizes, and variability in the degree of malnutrition and
pulmonary disease in the subject cohorts. Lower fat free mass
(FFM), a measure of both bone and muscle mass derived from
dual x-ray absorptiometry (DXA), indirectly estimates LBM and
has been associated with lower FEV1%-predicted and more fre-
quent pulmonary exacerbations in adults with CF (9–11). Adults
with unrecognized FFM depletion, defined as normal BMI and low
FFM, have lower FEV1%-predicted than adults with both normal
BMI and normal FFM (12). This finding highlights the limitation
of BMI as an informative marker of nutritional status in com-
plex chronic diseases such as CF (5). Similarly, DXA-derived LBM,
which estimates non-bone LBM, was correlated with degree of
lung function impairment in adults and with clinical severity score
in both children and adults in studies with small sample sizes (7,
13). In contrast, Williams et al. (14) studied body composition in
6- to 12-year-olds with PI-CF using a four-compartment model,
a technique limited to the research setting. Their study found that
girls with PI-CF had a significantly lower fat mass (FM) compared
to age-, height-, and puberty-matched controls, and that FM was
positively associated with FEV1%-predicted. This association was
not significant in males and no association was seen with FFM in
this cohort.
The extent to which worse nutritional status directly con-
tributes to worse pulmonary function has not been fully delin-
eated. Given the emphasis placed upon optimizing nutritional
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status in CF clinical care, interventions aimed at improving BMI,
and an emergence of obesity (15) in children and adults with CF,
an improved understanding of body composition especially fat
compared to muscle stores in CF health is indicated. The aim of
this study was to assess the associations of BMI and DXA-derived
measures of LBM and FM with lung function in a population
of children and adolescents with pancreatic insufficient CF (PI-
CF) without significant CF-related morbidities. We hypothesized
that the association of BMI and pulmonary function reflects the
association of LBM and pulmonary function.
MATERIALS AND METHODS
SUBJECTS
Individuals with PI-CF, aged 5–21 years were recruited from the
Cystic Fibrosis Centers at The Children’s Hospital of Philadelphia,
Philadelphia, PA, USA, the Hospital of the University of Pennsyl-
vania, Philadelphia, PA, USA, and multiple other CF Centers in
the United States (refer to acknowledgments). Data were collected
during the period from November 2000 to February 2002 for a
study on bone mineral content (16) and then again at baseline in
a separate cohort during a clinical trial from March 2007 to May
2011. The diagnoses of CF and pancreatic insufficiency were based
upon CFF recommendations.
Inclusion criteria included an FEV1%-predicted >40%. Sub-
jects were excluded for diabetes, cirrhosis or portal hypertension,
history of lung or liver transplant, or presence of other medical
conditions not associated with CF that could potentially affect
growth.
A group of 390 healthy Caucasian children and young adults,
aged 5–21 years were selected from the Philadelphia area as a con-
trol group (16). A separate group of 462 non-African American
subjects were evaluated at our center to generate contemporary ref-
erence data for growth and body composition (17); standard devi-
ation scores for CF subjects and healthy controls were generated
from these reference data.
For CF subjects, medical records were reviewed and data were
collected for genotype. CF genotype was categorized as homozy-
gous for ∆F508 mutation, compound heterozygous with one
∆F508 allele, or other variants.
ANTHROPOMETRY
Weight was measured using a digital scale (Scaltronix, White
Plains, NY, USA). Height was measured using a stadiometer
(Holtain, Crymych, UK). BMI (weight/height2) was calculated.
Age- and sex-adjusted Z -scores for height, weight, and BMI were
calculated using current reference data (18).
PUBERTY STAGING
Puberty status was ascertained using a validated self-assessment
questionnaire to categorize Tanner stages (TS) of pubic hair dis-
tribution (both sexes), and either genital development (males) or
breast development (females) (19).
DUAL ENERGY X-RAY ABSORPTIOMETRY
Spine and whole body DXA scans were acquired using a fan
beam array (Hologic Delphi, Bedford, MA, USA), and analyzed
using the Discovery software (version 12.3). Whole body scans
were analyzed to generate estimates of LBM (kilogram) and FM
(kilogram).
Lean body mass index (LBMI= LBM/height2) and fat mass
index (FMI= FM/height2) were calculated for the CF and con-
trols. Age-based reference curves were generated for males and
females from 462 healthy subjects using the lambda-mu-sigma
(LMS) method (20). LBMI and FMI were then converted to sex-
and age-adjusted Z -scores for the CF and controls using these
contemporary reference data.
SPIROMETRY
To assess pulmonary function, standard spirometry was per-
formed by subjects with CF. FEV1 was reported as the percentage of
predicted value (FEV1%-predicted) based upon prediction equa-
tions of Wang and Hankinson (21, 22). Forced vital capacity
(FVC) was similarly reported as percentage of predicted value
(FVC%-predicted).
STATISTICAL ANALYSES
Continuous variables were summarized using mean, median, and
standard deviation, and categorical variables were described using
proportions. Means for normally distributed data including age,
FEV1%-predicted, FVC%-predicted, BMI-Z, LBMI-Z, and FMI-Z
were compared using two-sided t -test; p< 0.05 was considered
statistically significant.
Linear regression was used to compare the relationships
between BMI-Z and (1) LBMI-Z and (2) FMI-Z in CF and
controls; since the relationship between BMI-Z and FMI-
Z is non-linear, BMI-Z squared was included in the FMI-Z
model. The interaction between BMI-Z and CF status was also
assessed.
The analyses were stratified by sex and multiple linear regres-
sion was used to assess the associations between body composition
(BMI-Z, LBMI-Z, and FMI-Z ) and pulmonary function (FEV1%-
predicted and FVC%-predicted). These associations were tested
individually and in combined models. The fit of each model was
evaluated by comparing the adjusted R2, likelihood ratio, and
Akaike information criterion (AIC). Models were adjusted for age
and age squared to account for the known age-related decline in
pulmonary function. The effects of puberty [pre-pubertal (Tan-
ner 1) vs. pubertal (Tanner 2–5)], race/ethnicity, type of CFTR
mutation, and colonizing pathogens in sputum culture on these
associations were tested. To test for effect modification by nutri-
tional status, subjects were also categorized by BMI, acceptable
(BMI≥ 50th‰) vs. sub-optimal BMI (<50th‰) (4).
The ability of BMI-Z < 0 vs. LBMI-Z < 0 to identify subjects
with FEV1%-predicted ≥80 and <80% adjusted for age and sex
was compared using logistic regression.
Regression diagnostics were performed on all models through
graphical checks, the Shapiro–Wilk test of normality of the residu-
als, and the Cook–Weisberg test for heteroscedasticity. All analyses
were performed using STATA 12 (StataCorp LP, College Station,
TX, USA).
The Institutional Review Boards at each of the participat-
ing institutions approved the study protocols, under which these
data were collected. Informed consent or assent was obtained as
appropriate.
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Table 1 | Characteristics of subjects (mean±SD).
Males Females
CF (n=111) Controls (n=182) p-Value CF (n=97) Controls (n=208) p-Value
Age 12.3±3.6 11.7±3.6 0.22 12.5±4.1 12.1±3.5 0.35
HT-Z −0.46±0.91 0.18±0.86 <0.0001 −0.46±0.99 0.19±0.82 <0.0001
WT-Z −0.51±0.90 0.24±0.89 <0.0001 −0.44±0.95 0.27±0.80 <0.0001
BMI-Z −0.33±0.83 0.16±0.96 <0.0001 −0.20±0.88 0.23±0.84 0.0001
LBMI-Z −0.63±0.94 0.01±1.0 <0.0001 −0.56±1.00 0.01±0.97 <0.0001
FMI-Z −0.37±0.87 0.00±1.0 0.0016 −0.39±1.00 −0.02±0.99 0.003
FEV1% 90±20 NAa – 88±21 NA –
FVC% 96±18 NA – 91±21 NA –
Race
Caucasian 101 (91%) 182 (100%) 85 (88%) 208 (100%)
Other 9 (8%) 0 8 (8%) 0
Unknown 1 (1%) 0 4 (4%) 0
Pubertal/pre-pubertal 75/36 113/69 0.88 73/24 154/54 0.47
RESULTS
POPULATION CHARACTERISTICS
Characteristics for subjects with CF and PI are summarized in
Table 1. A total of 211 subjects (114 males, 97 females), aged 5–
21 years with PI-CF were evaluated. Spirometry was not available
for three subjects. Data from the remaining 208 subjects were ana-
lyzed. Consistent with the known genetic epidemiology of CF, the
majority (90%) were Caucasian, and 72% had at least one ∆F508
CFTR mutation.
Males and females with CF were similar in age, and the various
pubertal stages were well-represented in both sexes. Mean growth
and body composition Z -scores were all <0 in the CF popula-
tion. No sex differences in weight-Z, height-Z, BMI-Z, LBMI-Z,
and FMI-Z overall, or within puberty groups (pre-pubertal or
pubertal) were identified (data not shown).
Lean body mass index-Z was positively associated with height-
Z (p< 0.0001) but the relationship was attenuated in the setting
of CF (p< 0.0001). LBMI-Z was also positively associated with
weight-Z (p< 0.0001) with a minor interaction between weight-
Z and CF status (p= 0.06) such that for a given weight-Z, CF
subjects have a lower LBMI-Z compared to controls. Similarly,
LBMI-Z was positively associated with BMI-Z in both CF and con-
trols, but this positive relationship was attenuated in the setting of
CF (p< 0.0001, Figure 1A and Table 2), even after adjustment for
puberty. Moreover, CF subjects with“sub-optimal” BMI (n= 131)
had lower mean LBMI-Z compared to controls with BMI< 50%
(n= 154) (p= 0.006).
The positive association between FMI-Z and height-Z was
blunted in the presence of CF (p= 0.001). In contrast, the positive
relationship of FMI-Z with weight-Z and weight-Z squared was
magnified in the presence of CF (p= 0.024). FMI-Z was positively
associated with BMI-Z (p< 0.0001) in CF and controls (Table 2)
after adjustment for puberty, but the relationship was not altered
by the presence of CF (Figure 1B).
PULMONARY FUNCTION AND BODY COMPOSITION
Cystic fibrosis subjects had a mean FEV1%-predicted 89± 21, and
a mean FVC%-predicted 96± 19. No difference in pulmonary
function was found between males and females with CF (p= 0.41).
Increasing age was associated with lower FEV1%-predicted (β-
coefficient=−2.1, CI: −2.8, −1.4, p< 0.0001, R2= 0.15). This
negative association was more pronounced in females than males
(decrease in FEV1% of 2.7 vs. 1.4% for each 1 year increase
in age).
Females
After adjusting for age, BMI-Z (p= 0.001), LBMI-Z (p< 0.0001),
and FMI-Z (0.046) were all positively associated with FEV1%-
predicted in females (Figure 2; Table 3). The relationship was
strongest with LBMI-Z (lowest AIC), and the association of
FMI-Z with FEV1%-predicted was no longer significant when
included in the model with LBMI-Z (p= 0.96). Pubertal status
did not alter the relationship of body composition and FEV1%-
predicted (p= 0.10). The relationship between LBMI-Z and
FEV1%-predicted was modified by nutritional status: in the set-
ting of “acceptable” BMI-Z (≥0) the effect of increasing LBMI-Z
on FEV1%-predicted was blunted (partial β-coefficient=−11.9;
p= 0.008).
Moreover, after adjustment for age, females with “accept-
able” LBMI-Z (Z ≥ 0 or LBMI≥ 50th‰) were five times more
likely to have an FEV1%-predicted >80% than females with low
LBMI-Z (<0) (OR= 5.1, p= 0.016) while females with accept-
able BMI-Z (≥0 or BMI≥ 50th‰) were about six times more
likely to have an FEV1%-predicted >80% (OR= 6.3, p= 0.002)
(Table 3).
Body mass index-Z was positively associated with age-
adjusted FVC%-predicted in females (partial β-coefficient= 4.6,
p= 0.046). Similarly, after adjustment for age, LBMI-Z was posi-
tively associated with FVC%-predicted (partial β-coefficient= 5.5,
p= 0.004). In contrast, FMI-Z was not associated with FVC%-
predicted (p= 0.11).
Males
As shown in Figure 2 and Table 3, BMI-Z (p< 0.0001) and
LBMI-Z (p< 0.0001), but not FMI-Z, were positively associated
with FEV1%-predicted after adjustment for age in males. Based
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FIGURE 1 | (A) The association between LBMI-Z and BMI-Z among healthy
controls and patients with CF. There is a positive association between
LBMI-Z and BMI-Z in all patients. Patients with CF have lower LBMI-Z for
BMI-Z compared to controls. (B) The association between FMI-Z and
BMI-Z among healthy controls and patients with CF. There is a positive
association between BMI-Z and FMI-Z in all patients that is not altered in
the presence of CF. Circles represent data points for controls and the solid
line represents the fitted line for controls. Crosses represent data points for
CF patients and the dashed line represents the fitted line for CF subjects.
on AIC, LBMI-Z was a better model than BMI-Z. Inclusion of
FMI-Z in the model with LBMI-Z did not improve the model,
and the association of FMI-Z with FEV1%-predicted remained
insignificant (p= 0.18). No interaction was found between LBMI-
Z and BMI% category (<50 vs. ≥50‰) in males (p= 0.68).
Pubertal status did not alter the relationship of body com-
position with FEV1%-predicted in this male CF population
(p= 0.41).
After age adjustment, males with acceptable LBMI-Z (≥0)
were about five times more likely to have an FEV1%-predicted
>80% than males with low LBMI-Z (OR= 5.5, p= 0.01). Males
with acceptable BMI-Z (≥0) were about four times more likely
to have an FEV1%-predicted >80% (OR= 3.99, p= 0.02) after
adjustment for age.
Body mass index-Z was also positively associated with age-
adjusted FVC%-predicted in males (partial β-coefficient= 4.6,
p= 0.02) after adjustment for age. Age-adjusted LBMI-Z was posi-
tively associated with FVC%-predicted (partial β-coefficient= 6.8,
p< 0.0001), but again FMI-Z was not associated with FVC%-
predicted (p= 0.16).
Table 2 | Association between BMI-Z and (1) LBMI-Z and (2) FMI-Z in
CF subjects (n=208) and controls (n=390) using linear regression.
Predictor variable Partial β
coefficient
95% CI p-Value R2
OUTCOME VARIABLE: LEAN BODY MASS INDEX-Z
Weight-Z 0.86 0.79, 0.95 <0.0001 0.57
Presence of CF −0.04 −0.16, 0.09 0.5
Weight-Z ×presence of CF −0.12 −0.25, 0.01 0.06
BMI-Z 0.94 0.89, 0.99 <0.0001 0.69
BMI-Z 0.92 0.86, 0.97 <0.0001 0.70
Presence of CF −0.18 −0.28, −0.08 <0.0001
BMI-Z 0.92 0.85, 0.98 <0.0001 0.70
Presence of CF −0.18 −0.28, −0.08 <0.0001
BMI-Z ×presence of CF −0.00004 −0.11, 0.11 0.99
OUTCOME VARIABLE: FAT MASS INDEX-Z
Weight-Z 0.76 0.70, 0.83 <0.0001 0.47
Weight-Z squared 0.14 0.10, 0.18 <0.0001
Presence of CF 0.15 0.02, 0.28 0.024
BMI-Z 0.88 0.83, 0.94 <0.0001 0.65
BMI-Z squared 0.17 0.13, 0.21 <0.0001
BMI-Z 0.89 0.84, 0.94 <0.0001 0.65
BMI-Z squared 0.17 0.13, 0.22 <0.0001
Presence of CF 0.06 −0.04, 0.16 0.24
DISCUSSION
Body mass index is typically used in the clinical care setting of
CF to assess nutritional status. In this study of generally healthy
youth with PI-CF, LBMI was more strongly associated with pul-
monary function than BMI was (particularly in males), while FMI
was not associated with pulmonary function. These findings sup-
port the hypothesis that the effect of better nutritional status in
CF is mediated through muscle mass, not FM, and that the asso-
ciation of total body mass with pulmonary function in CF reflects
an effect of LBM. However, CF is also associated with altered body
composition: individuals with CF have lower LBM than otherwise
healthy individuals with similar BMI-Z.
Lower LBM may result in respiratory muscle impairment of the
diaphragm or accessory respiratory muscles and lead to poorer
lung function (8, 23–25). Especially concerning would be the
loss of muscles involved in coughing, e.g., abdominal muscula-
ture. Alternatively, chronic pulmonary inflammation and infec-
tion result in a catabolic state, and lower LBM may reflect worse
lung disease (10). Systemic inflammation and malabsorption in
CF lend to protein and muscle loss (26). Decreased muscle is com-
pounded by decreased physical activity (27), inflammation (28),
and chronic glucocorticoid therapy (29).
Visceral fat is thought to contribute to metabolic abnormalities
by secreting inflammatory adipokines (30–33). A predisposition
toward accumulating FM in preference to LBM may induce addi-
tional inflammation in CF patients. This study did not distinguish
between visceral and subcutaneous fat, and, thus, this relationship
of visceral fat to pulmonary function cannot be directly tested here.
Among individuals with moderate to severe CF lung disease,
pancreatic insufficiency, and nutritional failure, improvements in
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FIGURE 2 | (A) The associations between FEV1%-predicted and BMI-Z
adjusted for age among males and females with CF. BMI-Z is positively
associated with FEV1%-predicted in males (p<0.0001) and females
(p=0.001) with CF. (B) The association between FEV1%-predicted and
LBMI-Z adjusted for age among males and females with CF. LBMI-Z is
positively associated with FEV1%-predicted in males (p<0.0001) and
females (p<0.0001). (C) The association between FEV1%-predicted and
FMI-Z adjusted for age among males and females with CF. No association
between FEV1%-predicted and FMI-Z was found in males (p=0.26) while
FMI-Z was positively associated with FEV1%-predicted in females
(p=0.046) with CF.
nutritional status are associated with improved lung function (2,
34). The benefit of targeting BMI≥ 50‰ is clear, and predictive
data from the logistic regression models in this study show a high
likelihood of having normal lung function when BMI-Z≥ 0. Better
expectations can be made for patients with LBMI-Z ≥ 0.
In otherwise healthy individuals, increases in BMI at lower BMI
generally reflect increases in LBM (35). This expected positive rela-
tionship between LBM and BMI seen in healthy individuals may be
disrupted by inflammation in chronic illnesses (35). In our study,
subjects with CF had lower LBMI-Z compared to controls with
similar BMI-Z. Moreover, subjects with CF had greater FMI-Z
compared to controls with similar Weight-Z, but this accumu-
lation of fat over LBM was not reflected in our BMI-Z models.
Instead, the relationship between FM and BMI-Z was similar to
that observed in controls: curvilinear such that at BMI-Z > 1, there
is proportionately greater FM (36), a relationship that was not
altered by the presence of CF.
Sex differences are also important. In females with
BMI< 50th‰, lower LBMI was associated with worse pulmonary
Table 3 | Relationship of body composition and pulmonary function in
CF.
Model Predictor
variable
Partial β
coefficient
p-Value R2 AIC
FEV1% PREDICTED
Females Age −2.3 <0.0001 0.34 834
BMI-Z 7.5 0.001
Age −2.4 <0.0001 0.38 811
LBMI-Z 8.0 <0.0001
Age −2.2 <0.0001 0.44 LR χ2=7.49 806
LBMI-Z 11.7 <0.0001 p=0.006
Optimal
BMIa×
LBMI-Z
−11.9 0.008
Age −2.4 <0.0001 0.26 827
FMI-Z 4 0.046
Age −2.4 <0.0001 0.37 814
LBMI-Z 7.9 <0.0001
FMI-Z 0.1 0.96
Males Age 9.46 0.004 0.23 960
Age2 −0.42 0.001
BMI-Z 7.8 <0.0001
Age 11.78 <0.0001 0.32 928
Age2 −0.51 <0.0001
LBMI-Z 9.77 <0.0001
Age 12.03 <0.0001 0.31 LR χ2=0.18 932
Age2 −0.52 <0.0001 p=0.67
Optimal
BMIa×
LBMI-Z
−2.2 0.68
Age 8.85 0.013 0.12 967
Age2 −0.39 0.004
FMI-Z −2.32 0.28
Age 11.67 <0.0001 0.33 929
Age2 −0.50 <0.0001
LBMI-Z 9.80 <0.0001
FMI-Z −2.48 0.18
aBMI less than (or) greater than or equal to 50 percentile.
function, whereas lower LBMI was associated with worse pul-
monary function in males regardless of whether BMI was greater
than or less than 50th‰. For two males with the same BMI,
the male with lower LBM will have lower pulmonary func-
tion regardless of whether or not the BMI is in the recom-
mended ≥50th‰ range (Table 2). In females, then, focusing
on intervening in patients with BMI< 50th‰ appears partic-
ularly relevant (Table 2). In contrast, focusing on males with
BMI< 50% may miss an important target group in the acceptable
BMI range.
Accrual of lean muscle mass is the logical aim of nutritional
and physical therapies. Aerobic fitness and survival in CF correlate
closely (37) and exercise training and habitual physical activity
improve muscle strength (38, 39), quality of life (40), and mucus
clearance (41). The extent to which physical activity impacted body
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composition and pulmonary function in the subjects in this study
was not explored.
Changes in body composition occur in males and females dur-
ing puberty (42). Males predominantly gain FFM while females
gain FM. In males, less LBM might reflect less physical activity,
worse disease, or lower androgen effect, all of which may result
from CF disease (43). However, our findings persisted even after
adjustment of our models for puberty in both males and females.
The extent to which the results of this cross-sectional study
of a relatively healthy CF population (mean FEV1%-predicted
89± 21) can be generalized to CF patients with poor lung function
and co-morbidities including severe liver disease and CF-related
diabetes is not clear. Additionally, longitudinal data are needed
to assess the temporal relationship between LBM and lung func-
tion and to examine LBM and FM accrual in CF. Until recently,
indices for FM and LBM have been unavailable outside the research
setting. Wells et al. recently published new body composition ref-
erence data for DXA and the four-compartment model (44), and
Weber et al. published LMI and FMI reference data based upon a
sample from NHANES (45). The availability of this reference data
may permit extension of these measures to the clinical setting.
Dual x-ray absorptiometry scanning is becoming increasingly
appealing due to widespread availability, its accuracy in measure-
ments (46, 47), and non-invasive nature. The 2005 Cystic Fibrosis
Foundation Consensus Conference (48) recommends screening
for decreased bone mineral density using DXA on select patients.
While these recommendations are targeted to assess bone struc-
ture and health, in certain individuals, especially underweight
females and males with low lung function suspected to be due
to poor nutrition, assessing LBM via DXA may identify LBM
depletion and could guide appropriate interventions. Recom-
mendations for obtaining screening DXA scans to assess body
composition will require more definitive longitudinal data that
support its utility over anthropometry alone. Furthermore, large
studies examining the effects of interventions on body compo-
sition are needed to pave the way for guidelines regarding the
CF population at risk for fat and LBM deficits. At this time,
BMI remains a good reflection of nutritional status although it
may not fully depict the altered body composition we identified
in CF.
In conclusion, we confirm that LBMI-Z is associated with
FEV1%-predicted and that LBM is lower than one would expect for
a given BMI. Thus, while BMI remains an adequate screening tool
in CF patients, determination of LBM may be useful for assessing
the relationship of body composition to pulmonary function par-
ticularly at lower BMI and in the clinical research setting; future
interventions in CF may better examine the impact upon LBM
with the use of DXA.
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